News

AddToAny

Google+ Facebook Twitter Twitter

New tool for medical biosensors

A team of US researchers have developed a new method using nanopores — nanometre-sized holes — to help scientists advance their discoveries in neuroscience and other medical applications.

For context – a single sheet of paper is about 100,000 nanometres thick.

Professor Li-Qun Gu said: “Potential applications include studying the structures of DNA- and RNA-based diseases and disorders, such as COVID-19, HIV and certain types of cancers, to see how drug therapies work.”

The technique involves aptamers, or single strands of DNA or RNA molecules that selectively bind to a specific target. This allows researchers to know exactly what they are detecting with the nanopores and study how individual molecules are interacting with each other.

bit.ly/45irS7F

Image Credit | iStock

Related Articles

The big question: Are we entering a new era in which mRNA vaccines are the future?

In May, AstraZeneca began the worldwide withdrawal of its COVID-19 vaccine, due to a “surplus of updated vaccines” that target new variants. Then in June, Moderna announced positive late-stage trial results for its single COVID/flu combination vaccine, mRNA-1083. On the back of this, we look at the future impact of mRNA vaccines.

Breast cancer CREDIT - Science Photolibrary- C0584739

Predicting the return of breast cancer

Dr Isaac Garcia-Murillas discusses a new blood test that can predict if breast cancer will return years before the disease shows on scans.

Restless leg syndrome - CREDIT Science Photolibrary- C0309748

Study points to potential treatments for restless leg syndrome

Scientists have discovered genetic clues to the cause of restless leg syndrome. The discovery could help identify those individuals at greatest risk of the condition and point to potential ways to treat it.

Stem cell transplant and cellular therapy lab

My lab: stem cell transplant and cellular therapy lab

Advanced Specialist Biomedical Scientist Mel Green gives a guided tour of the stem cell transplant lab at Nottingham University Hospitals.

Top